Original Research

Published on 12 Jun 2023

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response

in Pharmacology of Anti-Cancer Drugs

Chong Li
Keqian Zhang
Yuzhu Gong
Qinan Wu
Yanyan Zhang
Yan Dong
Dejia Li
Zhe Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200054

1,676 views

Editorial

Published on 09 Jun 2023

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more

in Pharmacology of Anti-Cancer Drugs

Zhi-Bin Wang
Dan Liu
Guang Lei
Zhao-Qian Liu
Nayiyuan Wu
Jing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222209

1,585 views

Original Research

Published on 08 Jun 2023

N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways

in Pharmacology of Anti-Cancer Drugs

Yan Hu
Zhe Zhao
Yuan-Ting Liu
Ze-Cheng Xu
Jing-Yi Li
Zheng-Yu Yang
Rui-Wang
Yun-Qi Yang
Jia-Hui Zhang
Si-Yuan Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164367

959 views

Original Research

Published on 08 Jun 2023

ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer

in Pharmacology of Anti-Cancer Drugs

Duntao Su
Zeyu Zhang
Fada Xia
Qiuju Liang
Yuanhong Liu
Wei Liu
Zhijie Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1202823

977 views

Review

Published on 08 Jun 2023

Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance

in Pharmacology of Anti-Cancer Drugs

Meiying Qin
Chunmei Zhang
Yang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194719

1,184 views

Systematic Review

Published on 08 Jun 2023

Efficacy and safety of consolidation durvalumab after chemoradiation therapy for stage III non-small-cell lung cancer: a systematic review, meta-analysis, and meta-regression of real-world studies

in Pharmacology of Anti-Cancer Drugs

Yatong Zhang
Yumei Tian
Li Zheng
Xuelin Sun
Zinan Zhao
Yujing Zheng
Jinhui Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1103927

2,152 views
2 citations

Review

Published on 08 Jun 2023

Natural products modulate cell apoptosis: a promising way for treating endometrial cancer

in Pharmacology of Anti-Cancer Drugs

Xin Zhou
Yiwei Zeng
Runchen Zheng
Yuemei Wang
Tao Li
Shanshan Song
Su Zhang
Jinzhu Huang
Yulan Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209412

1,860 views
1 citation

Review

Published on 07 Jun 2023

Mechanism of sorafenib resistance associated with ferroptosis in HCC

in Pharmacology of Anti-Cancer Drugs

Lingling Guo
Cuntao Hu
Mengwen Yao
Guang Han

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207496

3,455 views

Original Research

Published on 07 Jun 2023

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients

in Pharmacology of Anti-Cancer Drugs

Shuai Ma
Fang Wang
Qingzhen Liu
Xiaoteng Geng
Zaibin Wang
Menglei Yi
Fan Jiang
Dongtao Zhang
Junzheng Cao
Xiuwei Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170240

1,067 views

Review

Published on 06 Jun 2023

Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents

in Pharmacology of Anti-Cancer Drugs

Sheila I. Peña-Corona
Héctor Hernández-Parra
Sergio A. Bernal-Chávez
Néstor Mendoza-Muñoz
Alejandra Romero-Montero
María Luisa Del Prado-Audelo
Hernán Cortés
Dilek Arslan Ateşşahin
Solomon Habtemariam
Zainab M. Almarhoon

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1206334

1,554 views
2 citations

Editorial

Published on 06 Jun 2023

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics

in Pharmacology of Anti-Cancer Drugs

Balakumar Chandrasekaran
Muthupandian Saravanan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1229673

752 views

Original Research

Published on 02 Jun 2023

Selected cutaneous adverse events in patients treated with ICI monotherapy and combination therapy: a retrospective pharmacovigilance study and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Wenchao Lu
Huiyun Zhang
Qixiang Guo
Zhuoyue Gou
Jiannan Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1076473

1,659 views
1 citation

Review

Published on 02 Jun 2023

Circular RNAs in ferroptosis: regulation mechanism and potential clinical application in disease

in Pharmacology of Anti-Cancer Drugs

Fei Li
Pei-Feng Li
Xiao-Dan Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1173040

1,876 views
2 citations

Original Research

Published on 01 Jun 2023

Yiwei decoction promotes apoptosis of gastric cancer cells through spleen-derived exosomes

in Pharmacology of Anti-Cancer Drugs

Yingzhi Chen
Yu Li
Yue Wu
Shiyong Chen
Xiaoming Jin
Xuan Chen
Baoying Fei
Xiaomin Xue
Renzhao Wu
Kequn Chai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144955

1,378 views

Original Research

Published on 01 Jun 2023

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

Zelin Hou
Jiajing Lin
Yuan Ma
Haizhong Fang
Yuwei Wu
Zhijiang Chen
Xianchao Lin
Fengchun Lu
Shi Wen
Xunbin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1193791

3,067 views

Systematic Review

Published on 01 Jun 2023

Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Yanan Xu
Haijing Guan
Kefu Yu
Nan Ji
Zhigang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191480

2,039 views

Navigation group

Articles

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more

N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways

ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer

Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance

Efficacy and safety of consolidation durvalumab after chemoradiation therapy for stage III non-small-cell lung cancer: a systematic review, meta-analysis, and meta-regression of real-world studies

Natural products modulate cell apoptosis: a promising way for treating endometrial cancer

Mechanism of sorafenib resistance associated with ferroptosis in HCC

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients

Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics

Selected cutaneous adverse events in patients treated with ICI monotherapy and combination therapy: a retrospective pharmacovigilance study and meta-analysis

Circular RNAs in ferroptosis: regulation mechanism and potential clinical application in disease

Yiwei decoction promotes apoptosis of gastric cancer cells through spleen-derived exosomes

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis